Insider Trading Alert - OHI, SAM, DAL, EXPR And UVV Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 13, 2013, 169 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $704.00 to $43,077,002,500.00.

Highlighted Stocks Traded by Insiders:

Omega Healthcare Investors (OHI) - FREE Research Report

Korman Bernard J who is Director at Omega Healthcare Investors bought 46,070 shares at $31.15 on Nov. 13, 2013. Following this transaction, the Director owned 576,526 shares meaning that the stake was reduced by 8.68% with the 46,070 share transaction.

The shares most recently traded at $32.21, up $1.06, or 3.29% since the insider transaction. Historical insider transactions for Omega Healthcare Investors go as follows:

  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 9,975

The average volume for Omega Healthcare Investors has been 1.1 million shares per day over the past 30 days. Omega Healthcare Investors has a market cap of $3.9 billion and is part of the financial sector and real estate industry. Shares are up 32.12% year to date as of the close of trading on Tuesday.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. The stock currently has a dividend yield of 6.09%. The company has a P/E ratio of 22.7. Currently there is 1 analyst that rates Omega Healthcare Investors a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OHI - FREE

TheStreet Quant Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Omega Healthcare Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Don't Forget Why You Love Tech Stocks Like Amazon, Jim Cramer Explains

3 Stocks Poised for Gains Under the Donald Trump Era

3 Stocks That Will Perform Well Under a Trump Presidency

Income Pay Dirt: These 3 REITs Have Dividend Yields of Up to 12%

These 4 REITs Look Like Bargains After the Sector's Dive